How do I buy Personalis, Inc. Common Stock (PSNL) stock?

Buying Personalis, Inc. Common Stock (PSNL) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "PSNL", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy PSNL by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if PSNL is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Personalis, Inc. Common Stock (PSNL) Stock

Q: What is the minimum investment for PSNL on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Personalis, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · PSNL

Trade PSNL

Key stats

Market cap: $1.73B
Price / Earnings ratio: -14.4x
EPS (TTM): -$1.17
Volume: Loading
52-week high: $18.89
52-week low: $4.96

Source: third-party data provider, as of November 13, 2026

Compare with PSNL

Technical indicators

RSI 14: 52.06
MACD 12/26/9: -0.04
EMA 9 of MACD: -0.06
MACD histogram: 0.02
SMA 50: $16.12; Price below SMA 50
EMA 50: $15.72; Price above EMA 50
SMA 200: $11.52; Price above SMA 200
EMA 200: $12.25; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Hold

Based on 1 analyst rating

Strong Sell0

Sell0

Hold1

Buy0

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

103M68M34M0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

476M314M157M0

Revenue to Profit

2025

$69.6M

Revenue

$0.0

Cost of revenue

$15.8M

Gross profit

$0.0

Operating expenses

$-81.3M

Net income

Earnings

No data available

Source: third-party data provider

About Personalis, Inc. Common Stock

No description available.

SectorHealthcare

IndustryDiagnostics & Research

Employees259

CEOMr. Christopher M. Hall

IPO DateJun 20, 2019

HeadquartersFremont, CA

Key Executives

Name	Title	Year Born
Mr. Christopher M. Hall	CEO & Director	1969
Mr. Aaron L. Tachibana	CFO & COO	1961
Dr. Richard Chen M.D., M.S.	President & Chief Medical Officer	1971
Dr. Russ B. Altman M.D., Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board	—
Dr. Euan Angus Ashley DPHIL, FRCP, M.D., Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board	1971
Dr. Michael P. Snyder Ph.D.	Co-Founder and Member of Clinical & Scientific Advisory Board	—
Mr. Ashish Kheterpal	Senior VP & Chief Information Officer	—
Mr. Stephen M. Moore J.D.	Senior VP, Chief Legal Officer & Corporate Secretary	1972
Dr. Christian Haudenschild Ph.D.	Senior Vice President of Genomic Science	—
Mr. Stephane Mouradian Ph.D.	Senior Vice President of Business Development	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-21.2	+9.2
2022	-20.3	-10.6	-19.5	-35.9	-32.4	-5.0	+8.5	-9.3	-10.5	-20.5	-7.3	-27.5
2023	+16.9	+19.4	+5.3	-18.6	-22.4	-2.1	+26.9	-19.1	-34.6	-23.8	+61.1	+42.9
2024	-34.3	+20.2	-11.8	+2.8	-16.1	-19.3	+187.5	+52.4	+3.1	+2.4	-22.0	+48.2
2025	-16.7	-15.3	-14.6	+9.6	+19.9	+35.8	-16.6	-9.3	+35.6	+39.5	+19.2	-17.8
2026	+19.4	-3.1	-29.7	-15.9	+97.2	+19.0	-8.2	+27.1	-4.6	-2.2	+1.3

Stocks in the same sector

Labcorp Holdings Inc.

FAQ

Buying Personalis, Inc. Common Stock (PSNL) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "PSNL", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy PSNL by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Personalis, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Personalis, Inc. Common Stock (PSNL) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track PSNL's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Personalis, Inc. Common Stock (PSNL) Stock

Key stats

Compare with PSNL

Recent news

Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY

Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY

TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings

TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings

PSNL Legal Notice: Personalis Shareholders are Notified to Contact BFA Law About the Ongoing Investigation into the $16.25 per Share Merger

PSNL Legal Notice: Personalis Shareholders are Notified to Contact BFA Law About the Ongoing Investigation into the $16.25 per Share Merger

PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law

PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY

Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY

TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings

TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings

PSNL Legal Notice: Personalis Shareholders are Notified to Contact BFA Law About the Ongoing Investigation into the $16.25 per Share Merger

PSNL Legal Notice: Personalis Shareholders are Notified to Contact BFA Law About the Ongoing Investigation into the $16.25 per Share Merger

PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law

PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law

Personalis NeXT Personal® Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026

Personalis NeXT Personal® Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026

Personalis Brings Resistance Mutation Tracking to NeXT Personal® MRD Test

Personalis Brings Resistance Mutation Tracking to NeXT Personal® MRD Test

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms

SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future

SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future

TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight

TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight

Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

About Personalis, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade